Se ti disconnetti da Login UE, uscirai anche da tutti gli altri servizi che usano il tuo account Login UE. Utilizza il pulsante di disconnessione di CORDIS per rimanere connesso agli altri servizi.
Questa pagina sarà tradotta automaticamente dal servizio eTranslation della Commissione europea per facilitarne la comprensione. Leggi le condizioni d’uso.
ß-cell Dysfunction in Diabetes: Elucidating the Role of Islet-Associated Mesenchymal Cells
Final Report Summary - ISLETMESENCHYME (ß-cell Dysfunction in Diabetes: Elucidating the Role of Islet-Associated Mesenchymal Cells)
Glucose homeostasis relies on the tightly controlled release of insulin by pancreatic beta-cells. Diabetes, characterized by increased blood glucose levels, is a chronic disease that is now reaching epidemic proportions. The most common form of this disease is Type 2 diabetes (T2D), which was previously regarded as a disease of insulin resistance. However, work over the past decade has shifted this paradigm by implicating beta-cell failure as a critical factor in T2D. Despite significant progress, the cellular and molecular basis of T2D is far from being elucidated. Here, we characterize the role of an islet-associated mesenchymal cell population, pericytes, which have close contact with beta-cells in both human and mouse pancreata. Our findings revealed that in the adult pancreas, pericytes function to maintain beta-cell maturity and function, and hence are required for glucose homeostasis. In the new-born, pericytes promote proper proliferation of beta-cells. We further linked genetic predisposition to T2D in human with abnormal pericyte function. Our results indicate that T2D-related changes in pancreatic pericytes lead to impaired beta-cell function, resulting in abnormal glucose regulation. Finally, we found disease-related changes in pericytes production of secreted factors. Our findings point to pancreatic pericytes as a key component of the cellular network required for glucose regulation. Furthermore, our results propose that pathological changes in the islet niche are sufficient to cause beta-cell dysfunction and diabetes.